Genotype and Risk of Major Bleeding During Warfarin Treatment

Pharmacogenomics - United Kingdom
doi 10.2217/pgs.14.153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Exploring the Association Between Risk of Bleeding and Comorbid Conditions for Patients With Warfarin Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Fibrate/Statin Initiation in Warfarin Users and Gastrointestinal Bleeding Risk

American Journal of Medicine
Medicine
2010English

The Unrecognized Psychosocial Factors Contributing to Bleeding Risk in Warfarin Therapy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2011English

Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Drug-Drug Interactions and Risk of Bleeding Among Inpatients on Warfarin Therapy: A Prospective Observational Study

Thrombosis Journal
Hematology
2014English

Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding

Gastroenterology
HepatologyGastroenterology
2016English

Risk Factors for Major Bleeding in the SEATTLE II Trial

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2017English

Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding

JAMA - Journal of the American Medical Association
Medicine
2012English

International Warfarin Genotype-Guided Dosing Algorithms in the Turkish Population and Their Preventive Effects on Major and Life-Threatening Hemorrhagic Events

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy